Researcher.Life Logo

LYMPHOSIGN JOURNAL-THE JOURNAL OF INHERITED IMMUNE DISORDERS : Impact Factor & More

eISSN: 2292-5945pISSN: 2292-5937
Recommended pre-submission checks
Powered by Paperpal by Editage

LYMPHOSIGN JOURNAL-THE JOURNAL OF INHERITED IMMUNE DISORDERS Journal Specifications

Overview
Publisher LYMPHOSIGN JOURNAL LTD PARTNERSHIP
Language English
Frequency Quarterly
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2014
Website URLVisit website
View less

Planning to publish in LYMPHOSIGN JOURNAL-THE JOURNAL OF INHERITED IMMUNE DISORDERS ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in LYMPHOSIGN JOURNAL-THE JOURNAL OF INHERITED IMMUNE DISORDERS

A novel confirmed humoral immunodeficiency associated with <i>QARS1</i> mutation
  • 19 Feb 2026
  • LymphoSign Journal
A Novel Missense Variant in CTLA4 Associated with Immune Dysregulation
  • 19 Nov 2025
  • LymphoSign Journal
Phenotypic and Genetic Characterization of Heterozygous FOXN1 Variants: A Case Series of Mild Immunodeficiency
  • 19 Nov 2025
  • LymphoSign Journal
Primary immunodeficiencies related to folate and cobalamin transport and metabolism
  • 7 Oct 2025
  • LymphoSign Journal
Transition from Subcutaneous to Intravenous Immunoglobulin Therapy in Primary Immunodeficiency: A Case Series Highlighting Patient-Centered Treatment Optimization
  • 16 Jun 2025
  • LymphoSign Journal
2025 Canadian resource guides for individuals and families affected by primary immunodeficiency
  • 1 Mar 2025
  • LymphoSign Journal
A novel confirmed humoral immunodeficiency associated with <i>QARS1</i> mutation
  • 19 Feb 2026
  • LymphoSign Journal
A Novel Missense Variant in CTLA4 Associated with Immune Dysregulation
  • 19 Nov 2025
  • LymphoSign Journal
Phenotypic and Genetic Characterization of Heterozygous FOXN1 Variants: A Case Series of Mild Immunodeficiency
  • 19 Nov 2025
  • LymphoSign Journal
Primary immunodeficiencies related to folate and cobalamin transport and metabolism
  • 7 Oct 2025
  • LymphoSign Journal
Transition from Subcutaneous to Intravenous Immunoglobulin Therapy in Primary Immunodeficiency: A Case Series Highlighting Patient-Centered Treatment Optimization
  • 16 Jun 2025
  • LymphoSign Journal
2025 Canadian resource guides for individuals and families affected by primary immunodeficiency
  • 1 Mar 2025
  • LymphoSign Journal

FAQs on LYMPHOSIGN JOURNAL-THE JOURNAL OF INHERITED IMMUNE DISORDERS